This application seeks continuing funding for the Cancer Center Support Grant (CCSG) of the University of Chicago Cancer Research (UCCRC), now in its thirteenth year of operation. Since its establishment in 1973, the UCCRC has built or renovated 50,000 square feet and submitted 18 program grants which were approved and funded. In the period 1973-1989, over $39 million National Cancer Institute (NCI) awards for programs and building/renovation will have been made; during the same period, institutional commitment will be over $30 million. Current (10/31/85) annual sponsored programs in cancer research and training total $12.7 million with $10.7 million from NCI and other federal agencies. Over 90 members participate in four program areas: Viral Oncology, Cancer Biology and Carcinogenesis, Cancer Immunology, Clinical-Laboratory Cancer Research. There are four approved program grants: Viral Oncology Program Grant, Etiology of Treatment-Induced Secondary Leukemia Program Grant, Immunity and Cancer Program Grant, and Clinical-Laboratory Studies in Gynecologic Cancer Program Grant. A renovation program is currently under way which will permit major recruitment in basic science as well as in clinical cancer research areas. The funds sought in this application will support (1) the Professional Personnel consisting of the Director and Deputy Director, (2) The Administrative Office of the UCCRC, (3) the Planning and Evaluation functions, (4) the Viral Oncology Core Facility, (5) the Erman Core Laboratory in Cancer Biology, (6) the High Resolution NMR Spectroscopy and Mass Spectrometry Cancer Research Facility, (7) the Biostatistical and Data Management Core Facility, (8) the Oligopeptide Synthesis Core Facility, (9) The Animal Barrier Core Facility, and (10) New Investigators.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA014599-16
Application #
3101441
Study Section
Cancer Center Support Grant Review Committee (CCS)
Project Start
1977-02-01
Project End
1992-01-31
Budget Start
1989-02-01
Budget End
1990-01-31
Support Year
16
Fiscal Year
1989
Total Cost
Indirect Cost
Name
University of Chicago
Department
Type
Schools of Medicine
DUNS #
225410919
City
Chicago
State
IL
Country
United States
Zip Code
60637
Trujillo, Jonathan A; Sweis, Randy F; Bao, Riyue et al. (2018) T Cell-Inflamed versus Non-T Cell-Inflamed Tumors: A Conceptual Framework for Cancer Immunotherapy Drug Development and Combination Therapy Selection. Cancer Immunol Res 6:990-1000
Zeng, Zongyue; Huang, Bo; Huang, Shifeng et al. (2018) The development of a sensitive fluorescent protein-based transcript reporter for high throughput screening of negative modulators of lncRNAs. Genes Dis 5:62-74
Lee, Ji-Hye; Park, Beom Seok; Han, Kang R et al. (2018) Insight Into the Interaction Between RNA Polymerase and VPg for Murine Norovirus Replication. Front Microbiol 9:1466
Cheng, Jason X; Chen, Li; Li, Yuan et al. (2018) RNA cytosine methylation and methyltransferases mediate chromatin organization and 5-azacytidine response and resistance in leukaemia. Nat Commun 9:1163
Johnson, Marianna B; Hoffmann, Joscelyn N; You, Hannah M et al. (2018) Psychosocial Stress Exposure Disrupts Mammary Gland Development. J Mammary Gland Biol Neoplasia 23:59-73
Sweis, Randy F; Zha, Yuanyuan; Pass, Lomax et al. (2018) Pseudoprogression manifesting as recurrent ascites with anti-PD-1 immunotherapy in urothelial bladder cancer. J Immunother Cancer 6:24
Kathayat, Rahul S; Cao, Yang; Elvira, Pablo D et al. (2018) Active and dynamic mitochondrial S-depalmitoylation revealed by targeted fluorescent probes. Nat Commun 9:334
Liu, Jun; Eckert, Mark A; Harada, Bryan T et al. (2018) m6A mRNA methylation regulates AKT activity to promote the proliferation and tumorigenicity of endometrial cancer. Nat Cell Biol 20:1074-1083
Bhanvadia, Raj R; VanOpstall, Calvin; Brechka, Hannah et al. (2018) MEIS1 and MEIS2 Expression and Prostate Cancer Progression: A Role For HOXB13 Binding Partners in Metastatic Disease. Clin Cancer Res 24:3668-3680
Wood, Kevin; Byron, Elizabeth; Janisch, Linda et al. (2018) Capecitabine and Celecoxib as a Promising Therapy for Thymic Neoplasms. Am J Clin Oncol 41:963-966

Showing the most recent 10 out of 668 publications